The bill pertains to the provision of civil and criminal immunity in the context of in vitro fertilization (IVF). It stipulates that no legal action, whether civil or criminal, can be initiated for the damage to or death of an embryo against any individual or entity involved in providing or receiving IVF services. This immunity extends to manufacturers of goods used in the IVF process or in the transport of stored embryos. The bill also specifies that, in cases where damage to or death of an embryo is alleged against a manufacturer, any damages awarded shall be limited to the cost of the IVF cycle affected.

Furthermore, the bill has a retroactive effect, meaning it applies to acts, omissions, or services related to IVF that occurred before the enactment of the bill, provided they are not already the subject of ongoing litigation. The bill is described as remedial in nature, reinforcing its retroactive application. Upon enactment, the bill will take effect immediately, offering protection to those involved in the IVF process from potential legal repercussions related to embryo damage or death.